A phase 1 dose-escalation study of EC1456, a folic acid-tubulysin small-molecule drug conjugate, in adult patients (pts) with advanced solid tumors.
Wael A. Harb
Research Funding - Horizon Oncology Research
Ramesh K. Ramanathan
Research Funding - Endocyte
Daniela E. Matei
No relevant relationships to disclose
Binh Nguyen
Employment or Leadership Position - Endocyte
Stock Ownership - Endocyte
Edward A. Sausville
Research Funding - Endocyte